October 12th, 2021
NORD Offers Information and Support for Patients of Rare Cancers
November 24, 2014
Peter L. Saltonstall CURE, Winter 2014, Volume 13, Issue 4 NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become…
Uncategorized Posts
Saavan Patel 1, Ravi S Nunna 1, James S Ryoo 1, Darius Ansari 1, Nauman S Chaudhry 1, Ankit I Mehta 2 For more information: Outcomes and Patterns of Care in Adult Skull Base Chondrosarcoma Patients in the United States – PubMed…
October 11th, 2021
11 – 17 October 2021, we need your help! 76% of primary bone cancer patients in the UK are misdiagnosed and 14% of cases are in the skull, face and jaw. During #BoneCancerAwareness Week we’re educating dentists, dental healthcare professionals,…
October 7th, 2021
John Gross, M.D., M.S. This website is intended to promote education in bone and soft tissue pathology. Cases are presented in the format of radiologic images paired with scanned microscopic slides for the case. New cases will be uploaded every 8…
Bone Cancer Awareness Week 2021 11 – 17 October 2021, we need your help! 76% of primary bone cancer patients in the UK are misdiagnosed and 14% of cases are in the skull, face and jaw. During #BoneCancerAwareness Week we’re educating dentists,…
October 1st, 2021
Sep. 17, 2021TOPIC: Patients & Members, Advocacy, Patient Stories, Voices of Rare Cancer A Message to Chondrosarcoma Patients: Shayna’s Rare Cancer StoryPosted by Rohan Narayanan Shayna had advanced metastatic chondrosarcoma, and her…
September 30th, 2021
Get Involved, Spread the Word & Hear Stories From Those Impacted …
September 29th, 2021
Virtual Dialogue 3: Taking Charge of Your Care
Third International Virtual Dialogue The Chondrosarcoma CS Foundation, Inc. held the Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma survivors and prominent experts to…
September 15th, 2021
Rare Disease Innovation and Data Sharing Accelerated by New RDCA-DAP Program TUCSON, Ariz. and WASHINGTON, September 15, 2021 — The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP ®) officially launched its next…
September 14th, 2021
Study Description
Go to Brief Summary:
This phase II trial studies how well atezolizumab works in treating patients with chondrosarcoma or clear cell sarcoma that is newly diagnosed, cannot be removed by surgery (unresectable), or has spread to…